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We thank O’Connor and Fraser for their comments, which 
suggest a diﬀ   ering association between early and late 
hyperlactatemia and mortality in post-operative cardiac 
surgery patients and that the inclusion of this cohort in our 
‘cardiac/vascular’ group may have weakened the asso-
ciation between lactate and mortality in our study.
Th   ey are correct in assuming that a signiﬁ  cant number 
of patients from the ‘cardiac/vascular’ group were post-
operative cardiac patients, as three of the four intensive 
care units in our study support busy cardiothoracic 
services. Unfortunately, the coding of our database 
prevents us from identifying these patients in more detail. 
However, we were able to separate and examine the 
cardiac/vascular group, the surgical group, and the 
cardiac/vascular patients who underwent surgery. In the 
cardiac/vascular surgical group, the risk of death was 
increased with hyperlactatemia compared with all of the 
other groups (Table 1). In addition, the risk of death 
determined by maximal and time-weighted lactate (more 
strongly reﬂ   ecting post-admission lactate levels) was 
greater in the cardiac/vascular surgical group compared 
with the other groups (Table 1).
Th  ese  ﬁ  ndings demonstrate that early (admission) and 
late (post-admission) hyperlactatemia are both strongly 
associated with mortality in cardiac/vascular surgical 
patients (of whom a signiﬁ   cant number were post-
operative cardiac patients). Th  is would suggest that the 
inclusion of cardiac surgical patients did not weaken the 
association with mortality; it actually strengthened the 
overall association. Th  ese  ﬁ  ndings demand more study of 
lactate in the cardiac surgical cohort, and we eagerly 
await the publication of the results alluded to by 
O’Connor and Fraser.
We read with interest the article by Nichol and colleagues 
[1] in a recent issue of Critical Care. Th   eir study of more 
than 7,000 medical and surgical patients supports the 
claim that an admission plasma lactate level in the upper 
normal range is associated with increased mortality. 
However, we are concerned about the lack of data regard-
ing patient baseline characteristics. Speciﬁ  cally, although 
3,166 and 1,614 patients had diagnoses of ‘surgery’ and 
‘cardiac/vascular’, respectively, it is likely, but not stated, 
that numerous patients were admitted following cardiac 
surgery. Th   is is of great importance as changes in lactate 
in this patient group are not homogenous in nature.
In post-cardiac surgery patients, early hyperlactatemia 
and late hyperlactatemia (LHL) diﬀ  er in both risk proﬁ  le 
and physiological rationale. Early hyperlactatemia (on 
intensive care unit arrival) is associated with adverse 
outcome. Th   is association is not seen in the 10% to 20% 
of patients who develop LHL (pooled odds ratio [OR] of 
death with LHL in two published trials 1.39, 95% 
conﬁ  dence interval [CI] 0.28 to 7.04) [2-4]. Moreover, in 
our recent single-center review of prospectively collated 
data from 529 post-cardiac surgical patients in a tertiary 
Australian cardiac surgical intensive care unit, 25% 
developed LHL (>2.5  mmol/L). When compared with 
patients with a normal lactate proﬁ  le, patients with LHL 
showed no increase in hospital mortality (OR 0.57, 95% 
CI 0.07 to 5.05) (unpublished data).
Th   erefore, we believe that inclusion of such patients in 
studies of lactate in critical illness should be avoided and, 
as in the study by Nichol and colleagues, may actually 
weaken any association demonstrated between lactate 
levels and hospital mortality.
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Table 1. Odds ratios of mortality for a 1-unit increase in lactate, adjusting for gender, age, APACHE II, mechanical 
ventilation, and diagnosis type considering the full dataset and three subgroups
Lactate variable  Number  Odds ratio  Lower 95% CI  Upper 95% CI  Group
LacADM 7,155  1.12  1.09  1.16  Full  Group
LacADM 3,166  1.18  1.11  1.26  Surg  Only
LacADM 1,614  1.13  1.07  1.21  Card/Vasc  Only
LacADM  743  1.35  1.14  1.60  Card/Vasc & Surg Only
LacMAX 7,155  1.15  1.12  1.17  Full  Group
LacMAX 3,166  1.14  1.10  1.19  Surg  Only
LacMAX 1,614  1.11  1.06  1.15  Card/Vasc  Only
LacMAX  743  1.18  1.09  1.27  Card/Vasc & Surg Only
LacTW   7,155  2.08  1.90  2.27  Full Group
LacTW   3,166  2.17  1.83  2.57  Surg Only
LacTW   1,614  2.37  1.92  2.93  Card/Vasc Only
LacTW   743  4.16  2.45  7.07  Card/Vasc & Surg Only
APACHE II, Acute Physiology and Chronic Health Evaluation II; Card/Vasc Only, only cardiac/vascular patients; Card/Vasc & Surg Only, only cardiac/vascular surgery 
patients; CI, confi  dence interval; Full group, all patients admitted to the intensive care unit during the study period; LacADM, intensive care unit admission lactate 
concentration; LacMAX, maximal lactate concentration; LacTW, time-weighted lactate concentration; Surg Only, only surgery patients.
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